Prime Medicine grants CFO options on 800,000 shares
Prime Medicine, Inc. reported that Chief Financial Officer Svetlana Ni Makhni received a grant of stock options covering 800,000 shares of common stock.
Rhea-AI Filing Summary
Prime Medicine, Inc. reported that Chief Financial Officer Svetlana Ni Makhni received a grant of stock options covering 800,000 shares of common stock. The options have an exercise price of $3.67 per share and expire on April 16, 2036.
According to the terms, 25% of the shares underlying this option will vest on April 16, 2027, with the remaining shares vesting in equal monthly installments over the following 36 months, subject to her continued service. After this grant, she holds options on 800,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 800,000 shares
Grant/Award
1 txn
Insider
Makhni Svetlana Ni
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 800,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 800,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares underlying this option shall vest on April 16, 2027 and the balance will vest monthly in equal instalments over the following 36 months, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Option grant size: 800,000 options
Exercise price: $3.67 per share
Expiration date: April 16, 2036
+4 more
7 metrics
Option grant size
800,000 options
Stock Option (right to buy) granted to CFO
Exercise price
$3.67 per share
Conversion or exercise price of the option
Expiration date
April 16, 2036
Option term end date
Underlying shares
800,000 shares
Common Stock underlying the option
Initial vesting cliff
25% on April 16, 2027
Portion of options that vest on first vesting date
Remaining vesting period
36 months
Monthly vesting period after initial 25% cliff
Post-grant holdings
800,000 options
Total options held following the transaction
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 3.6700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying this option shall vest on April 16, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-04-16T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Prime Medicine (PRME) disclose about its CFO in this Form 4?
Prime Medicine reported that CFO Svetlana Ni Makhni received a stock option grant for 800,000 shares of common stock at a $3.67 exercise price. These options are a compensation award, not an open-market stock purchase or sale, and vest over several years.
What is the exercise price and term of the CFO’s Prime Medicine (PRME) options?
The granted stock options have an exercise price of $3.67 per share and expire on April 16, 2036. This gives the CFO a long window to potentially purchase shares at that set price once the options have vested over time.
How do the Prime Medicine (PRME) options granted to the CFO vest over time?
Twenty-five percent of the shares underlying this option vest on April 16, 2027. The remaining 75% then vest in equal monthly installments over the following 36 months, provided the CFO continues in service on each vesting date.
Is the Prime Medicine (PRME) CFO’s option grant an open-market transaction?
No. The filing describes an “A” code grant, meaning it is a compensation-related award, not an open-market buy or sell. The CFO did not purchase shares in the market; instead, she received options giving the right to buy future shares at $3.67.
AI-generated analysis. How Rhea-AI works. Not financial advice.
